Shelton Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Shelton Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,600	Closed	-$1.29M	–	772
2024 Q1	$1.29M	Hold	13,600	–	–	0.04%	266
2023 Q4	$1.21M	Hold	13,600	–	–	0.04%	262
2023 Q3	$993K	Hold	13,600	–	–	0.04%	268
2023 Q2	$1.13M	Sell	13,600 -80	-0.6%	-$6.69K	0.04%	260
2023 Q1	$1.04M	Hold	13,680	–	–	0.04%	236
2022 Q4	$1.14M	Buy	13,680 +80	+0.6%	+$6.48K	0.12%	197
2022 Q3	$1.08M	Hold	13,600	–	–	0.05%	237
2022 Q2	$1.01M	Hold	13,600	–	–	0.05%	254
2022 Q1	$1.22M	Hold	13,600	–	–	0.05%	258
2021 Q4	$1.52M	Hold	13,600	–	–	0.05%	250
2021 Q3	$1.71M	Hold	13,600	–	–	0.07%	239
2021 Q2	$1.84M	Hold	13,600	–	–	0.07%	234
2021 Q1	$1.84M	Hold	13,600	–	–	0.06%	249
2020 Q4	$1.92M	Buy	13,600 +2,800	+26%	+$359K	0.09%	210
2020 Q3	$1.2M	Sell	10,800 -1,200	-10%	-$135K	0.05%	325
2020 Q2	$1.34M	Hold	12,000	–	–	0.07%	218
2020 Q1	$929K	Hold	12,000	–	–	0.07%	227
2019 Q4	$1.14M	Buy	+12,000	New	+$1.04M	0.06%	226

Other funds holding XBI

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Shelton Capital Management's XBI Position: Q2 2024 in Review

Shelton Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 13,600 shares — an estimated $1.29M sold.

Shelton Capital Management first reported a position in XBI in Q4 2019 and held it in 18 quarters. The position peaked at $1.92M in Q4 2020. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Shelton Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Shelton Capital Management sold 13,600 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $1.29M.
Shelton Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 18 quarters.
Shelton Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.92M in Q4 2020.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Shelton Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.